About Medgenome Labs Limited
Data last updated: 06 January 2026
Medgenome Labs Limited is a public limited company based in Bangalore South, Karnataka, India, a subsidiary of Medgenome Inc.. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 08 April 2013, the company has been in operation for over 13 years.
Registered with ROC Bangalore under CIN U73100KA2013PTC084414.
Capital: an authorised share capital of ₹7 Cr and a paid-up capital of ₹5.91 Cr. Formerly known as Medgenome Labs Private Limited. It is led by directors including Suryaprakasam Vedam Lakshmi Ramprasad and Surajit Chakrabartty.
Last AGM: 27 November 2025. Financial statements filed for year ended 31 March 2025. Office: Bangalore South, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹406.98 Cr, a growth of 36% compared to the previous year.
The company has a workforce of approximately 883 employees as per the latest available data. It operates as a subsidiary of Medgenome Inc..
The company is associated with 2 brands - Medgenome, Oneassist. As per MCA filings, the company has open charges of ₹3.3 Cr and satisfied charges of ₹55.27 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medgenome.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Apps
-
Registered AddressSy. Nos. 94/1C And 94/2 Tower 1 Ground Floor, Veerasandra Village Attibele Hobli Electronic City Phase – 1, Bangalore South, Karnataka, India – 560100
-
IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Medgenome Labs Limited
Medgenome Labs Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U73100KA2013PLC084414, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100KA2013PLC084414 | Current |
| U73100KA2013PTC084414 | Previous |
| U73100TN2013PTC090471 | Previous |
Associated Brands with Medgenome Labs Limited
Medgenome Labs Limited operates two associated brands: MedGenome and OneAssist. These brands represent Medgenome Labs Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| DNA sequencing, bioinformatics, and multiomics services are provided. | medgenome.com | |
| Provider of protection plans and repair services for gadgets and appliances | oneassist.in |
Competitors & Alternatives of Medgenome Labs Limited
Brands and companies operating in the same space as Medgenome Labs Limited include Foundation Medicine, Personalis, Novogene Corporation and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Foundation Medicine
|
Genomics-based diagnostic tests for cancer are provided. | Cambridge, United States, United States | 2010 |
Personalis
|
Genomic sequencing and diagnosis software is provided for healthcare. | Menlo Park, United States, United States | 2011 |
Novogene Corporation
|
Genomic services and solutions with NGS expertise are provided. | Beijing, China, China | 2011 |
Onsitego
|
Extended warranties for electronics are offered via an online platform. | Mumbai, India, India | 2010 |
Lantern Pharma
|
Drug and companion diagnostics for multi-drug resistant cancers are developed. | Dallas, United States, United States | 2013 |
Burning Rock
|
Personalized cancer diagnostics are developed using genomic big data analysis. | Guangzhou, China, China | 2014 |
Zhejiang Nuhui Health Technology
|
Provider of early cancer screening and testing services | Beijing, China, China | 2013 |
Veritas Genetics
|
Genetic testing products for health risks and traits are offered. | Danvers, United States, United States | 2014 |
3billion
|
AI-driven diagnostic platform for rare genetic diseases is offered. | Seoul, South Korea, South Korea | 2016 |
Syska Gadget Secure
|
Provides insurance coverage for mobile phones. | Pune, India, India | 2014 |
Business Activity of Medgenome Labs Limited
Medgenome Labs Limited is engaged in principal business activities including professional, scientific and technical and hospital and medical care, with detailed activities including scientific research and development, other hospital and medical care activities. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | ********* |
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | ********* |
Board of Directors of Medgenome Labs Limited
Medgenome Labs Limited is currently managed by 7 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Suryaprakasam Vedam Lakshmi Ramprasad
Also directs:
Green Cross Genetics Lab Private Limited, Genx Diagnostics Limited, Immucare Diagnostics Private Limited and 3 more
|
Ceo | 16 Nov 2023 | 2 Years 7 Months | Current |
|
Surajit Chakrabartty
Also directs:
Ekavidha Corporate Services Private Limited, Green Cross Genetics Lab Private Limited, Genx Diagnostics Limited and 4 more
|
Cfo | 01 Dec 2014 | 11 Years 7 Months | Current |
| Navjeewan Jatinder Khosla | Director | 07 Nov 2024 | 1 Years 8 Months | Current |
| Prasad Bhagwan Shejale | Director | 30 Sep 2019 | 6 Years 9 Months | Current |
| Mahesh Pratapneni | Director | 30 Sep 2014 | 11 Years 9 Months | Current |
|
Shankar Mahadevappa Prasad
Also directs:
Ekavidha Corporate Services Private Limited
|
Director | 24 Dec 2018 | 7 Years 6 Months | Current |
Financials of Medgenome Labs Limited FY 2025 filings available
Medgenome Labs Limited reported revenue of ₹406.98 Cr (up 36% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Medgenome Labs Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2023 | Hdfc Bank Limited | ₹3.3 Cr | Open |
| 26 Jun 2019 | Others | ₹9.1 Cr | Satisfied |
| 15 Mar 2019 | Hdfc Bank Limited | ₹16.92 Cr | Satisfied |
| 02 Jun 2015 | Hdfc Bank Limited | ₹29.25 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Medgenome Labs Limited
View historical data on people associated with Medgenome Labs Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Medgenome Labs Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Medgenome Labs Limited
GSTIN & GST Filing Data of Medgenome Labs Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Medgenome Labs Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Medgenome Labs Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Medgenome Labs Limited
MSME Payment Delays by Medgenome Labs Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Medgenome Labs Limited
Subsidiaries & Group Companies of Medgenome Labs Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Medgenome Labs Limited with ownership details.
MCA Filings & Documents of Medgenome Labs Limited
MCA Filings & Documents of Medgenome Labs Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Medgenome Labs Limited
Recent News on Medgenome Labs Limited
Frequently Asked Questions about Medgenome Labs Limited
Medgenome Labs Limited is an active public limited company in the healthcare sector based in Bangalore South, Karnataka, India. It was incorporated on 08 April 2013 (13+ years old) and is registered under CIN U73100KA2013PLC084414. The company has 883 employees.
Medgenome Labs Limited reported revenue of ₹406.98 Cr for FY 2025 (up 36.00% YoY).
The current directors of Medgenome Labs Limited are:
- Suryaprakasam Vedam Lakshmi Ramprasad
- Surajit Chakrabartty
- Navjeewan Jatinder Khosla
- Prasad Bhagwan Shejale
- Mahesh Pratapneni
- Shankar Mahadevappa Prasad
- Suryaprakasam Vedam Lakshmi Ramprasad
The primary industry of Medgenome Labs Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.
Medgenome Labs Limited can be reached at the registered office: Sy. Nos. 941C And 942 Tower 1 Ground Floor, Veerasandra Village Attibele Hobli Electronic City Phase – 1, Bangalore South, Karnataka, India – 560100, or through the website medgenome.com.
The authorised capital is ₹7 Cr, and the paid-up capital is ₹5.91 Cr.